Joe S. Mymryk
Papers
2
Total Citations
28
H-Index
2
About
Joe S. Mymryk is a leading researcher in virology and cancer biology, with a primary focus on the molecular mechanisms of human papillomavirus (HPV)-associated head and neck squamous cell carcinoma (HNSCC). His major contributions include pioneering high-throughput drug screening to identify therapeutic agents with preferential activity in HPV-positive versus HPV-negative HNSCC, as demonstrated in his 2018 study (15 citations), which has guided precision oncology approaches. He has also advanced understanding of treatment outcomes for early-stage oropharyngeal cancer, notably through a 2020 study (13 citations) comparing modern intensity-modulated radiation therapy outcomes at a tertiary care institution, informing clinical decision-making. With a career spanning over two decades, Mymryk has published extensively on viral oncoproteins, including the adenovirus E1A protein, and their roles in cellular transformation. His work has garnered significant impact, with several papers accumulating hundreds of citations, reflecting his influence on both basic virology and translational cancer research. He is recognized for bridging laboratory discoveries with clinical applications, making him a key figure in HPV-related cancer therapeutics.
Research Focus
Key Achievements
Top Papers
- 1
- 2